相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Reduced Mortality of Staphylococcus aureus Bacteremia in a Retrospective Cohort Study of 2139 Patients: 2007-2015
Eloise D. Austin et al.
CLINICAL INFECTIOUS DISEASES (2020)
Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort Study
Sarah C. J. Jorgensen et al.
CLINICAL INFECTIOUS DISEASES (2020)
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia A Randomized Clinical Trial
Steven Y. C. Tong et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments
Erin K. McCreary et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Monotherapy with Vancomycin or Daptomycin versus Combination Therapy with β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus Aureus Bloodstream Infections: A Retrospective Cohort Analysis
Sara Alosaimy et al.
INFECTIOUS DISEASES AND THERAPY (2020)
Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
Matthew Geriak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections - United States
Athena P. Kourtis et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2019)
The Impact of Concomitant Empiric Cefepime on Patient Outcomes of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections Treated With Vancomycin
Evan J. Zasowski et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
Piperacillin/Tazobactam and Antibiotic-Associated Acute Kidney Injury in Critically Ill Children
Emily L. Joyce et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
2250. Combination Vancomycin Plus Cefazolin for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
Sarah C J Jorgensen et al.
Open Forum Infectious Diseases (2019)
Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range
Dehui Luo et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2018)
Physical Activity and Incident Depression: A Meta-Analysis of Prospective Cohort Studies
Felipe B. Schuch et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Survival following Staphylococcus aureus bloodstream infection: A prospective multinational cohort study assessing the impact of place of care
Kate Nambiar et al.
JOURNAL OF INFECTION (2018)
Outcomes of Vancomycin plus a β-Lactam versus Vancomycin Only for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
James Truong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Synergistic effects of vancomycin and β-lactams against vancomycin highly resistant Staphylococcus aureus
Fumiaki Tabuchi et al.
JOURNAL OF ANTIBIOTICS (2017)
Early Administration of Adjuvant -Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis
Anthony M. Casapao et al.
PHARMACOTHERAPY (2017)
A combination of ceftaroline and daptomycin has synergistic and bactericidal activity in vitro against daptomycin nonsusceptible methicillin-resistant Staphylococcus aureus (MRSA)
Iffat Shafiq et al.
INFECTIOUS DISEASES (2017)
Combination Vancomycin/Cefazolin (VAN/CFZ) for Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections (BSI)
Trang D Trinh et al.
Open Forum Infectious Diseases (2017)
Combination of Vancomycin and β-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial
Joshua S. Davis et al.
CLINICAL INFECTIOUS DISEASES (2016)
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
Steven Y. C. Tong et al.
CLINICAL MICROBIOLOGY REVIEWS (2015)
Combination Antibiotic Treatment of Serious Methicillin-Resistant Staphylococcus aureus Infections
J. S. Davis et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
β-Lactams Enhance Vancomycin Activity against Methicillin-Resistant Staphylococcus aureus Bacteremia Compared to Vancomycin Alone
Thomas J. Dilworth et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
Xiang Wan et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
Vancomycin and Piperacillin-Tazobactam Against Methicillin-Resistant Staphylococcus aureus and Vancomycin-Intermediate Staphylococcus aureus in an In Vitro Pharmacokinetic/Pharmacodynamic Model
Thomas J. Dilworth et al.
CLINICAL THERAPEUTICS (2014)
Daptomycin in Combination With Other Antibiotics for the Treatment of Complicated Methicillin-Resistant Staphylococcus aureus Bacteremia
Abhay Dhand et al.
CLINICAL THERAPEUTICS (2014)
Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus
George Sakoulas et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Ceftaroline Increases Membrane Binding and Enhances the Activity of Daptomycin against Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model
Brian J. Werth et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
β-Lactams Increase the Antibacterial Activity of Daptomycin against Clinical Methicillin-Resistant Staphylococcus aureus Strains and Prevent Selection of Daptomycin-Resistant Derivatives
Shrenik Mehta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children
Catherine Liu et al.
CLINICAL INFECTIOUS DISEASES (2011)
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
Vance G. Fowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
分享论文
